Details for New Drug Application (NDA): 020569
✉ Email this page to a colleague
The generic ingredient in VITRASERT is ganciclovir. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ganciclovir profile page.
Summary for 020569
Tradename: | VITRASERT |
Applicant: | Bausch And Lomb |
Ingredient: | ganciclovir |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020569
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | IMPLANT;IMPLANTATION | Strength | 4.5MG | ||||
Approval Date: | Mar 4, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020569
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb | VITRASERT | ganciclovir | IMPLANT;IMPLANTATION | 020569-001 | Mar 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription